Cargando…
HGG-32. Durable response to mTOR inhibitor after failing Checkpoint inhibitors in Ultra-Hypermutated High grade glioma in context of CMMRD
BACKGROUND: Paediatric High Grade Gliomas (HGG) have poor outcomes with conventional treatment. HGG in association with constitutional DNA mismatch repair deficiency (CMMRD) are hypermutated and have shown dramatic response to checkpoint inhibitors. Salvage following progression or failure to respon...
Autores principales: | Hegde, Kriti, Dahl, Christine, Depani, Sarita, Hargrave, Darren, Oostveen, Minou, Aguirregomezcorta, Fernando, Jeelani, Owase, Aquilina, Kristian, Gains, Jenny, Ching, Yen, Jacues, Thomas, Merve, Ashirwad, Chalker, Jane, Addy, Dilys, Ahmed, Saira W, Yasin, Shireen, Mankad, Kshitij, Carney, Olivia, Sudhakar, Sniya, D'Arco, Felice, Loebel, Ulrike, Jorgensen, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165311/ http://dx.doi.org/10.1093/neuonc/noac079.247 |
Ejemplares similares
-
HGG-40. NF1 mosaicism in a CMMRD-patient with a glioblastoma
por: Guerrini-Rousseau, Lea, et al.
Publicado: (2022) -
MEDB-48. Infant medulloblastoma - SHH subtype – with residual disease. To treat or not to treat
por: Dahl, Christine, et al.
Publicado: (2022) -
HGG-58. SIOPE HGG Working Group approach to obtain consensus on management of paediatric high grade glioma across Europe
por: Giraud, Géraldine, et al.
Publicado: (2022) -
HGG-33. EXPLOITING METABOLIC DEFECTS WITH NAMPT INHIBITORS IN DIPG
por: Muraleedharan, Ranjithmenon, et al.
Publicado: (2021) -
HGG-06. REMARKABLE RESPONSE TO BRAF INHIBITOR IN AN INFANT WITH DISSEMINATED DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT)
por: Aung, Le Le
Publicado: (2020)